Two Years Maintenance of Structured Group Self-management Education in Type 2 Diabetes : a Randomized Controlled Trial (ERMIES)

Multicenter Randomized Trial of Structured Educational Intervention at the Community Level in Insufficiently Controlled Patients With Type 2 Diabetes in Reunion Island

Type 2 diabetes has a growing impact on populations and public health worldwide. Clinical trials have clearly demonstrated that a better control of blood glucose level and of other risk factors is efficient in preventing or retarding the complications of the disease. On Reunion island, Type 2 diabetes is present in 18% of population aged 30 or older with a high level of socio-economic deprivation. The hypothesis of the ERMIES study is that a structured group self-management education maintained at the community level for 2 years in patients with insufficiently controlled type 2 diabetes has better metabolic results (as attested by improvement in HbA1c level) at 2 yrs, compared to an initial short term (< 3 months) self-management program, based on the same theoretical basis and framework (learning nests empowerment). A total of 240 adults living in Reunion Island, with type 2 diabetes mellitus with HbA1c ≥ 7.5% on a stable treatment for at least 3 months will be randomly allocated to 2 intervention arms: either a short term (< 3 months) program (1 to 7 thematic 2-hr long sessions depending on individual assessment), or a long term program including the same initial program as 1st arm, but with group self management education sessions, maintained for 2 years (4-monthly assessment, empowerment, and contextual action planning; facultative additional specific thematic sessions being delivered if needed). Medical visits will be held quarterly for the recording of outcome measures (HbA1c, blood pressure, anthropometrics, tobacco consumption, diabetes complications) and yearly for blood glucose, lipids, micro-albuminuria or proteinuria, creatinine clearance, diet and exercise (questionnaires), treatment recording, quality of life, self-efficacy, anxiety and depression scales, and social support.

Study Overview

Detailed Description

Randomised clinical trial comparing 2 parallel arms of educational intervention with the hypothesis of the superiority of a 2-year maintenance of a structured, theoretically-based, educational follow-up. All subjects of both arms will beneficiate from an initial structured educational program (< 3-months). Subjects, educators, and investigators will be unaware of the group allocation during this initial round. Then the intervention arm will undergo a 2 years self management educational follow-up program. Randomisation will be stratified on 2 factors : centres (5 strata) and anti diabetic treatment (2 strata: insulin-treated or not). All group sessions (3-10 subjects, 2 hr-long, one assessment group session and 6 facultative additional specific sessions for each round [initial in both arms or follow-up in the intervention arm], as needed and planned during the first) will be held at the community level, as closer as possible to the subjects' residence. Educators are specifically trained and the educational sessions are structured and coordinated in the framing and organisational supervision of the health management network "ReuCARE" in Reunion island. Subjects of both arms will continue quarterly to attend at the outpatient clinic of the centre. This trial is associated to a qualitative ethno-sociological study on a sample of 30-40 subjects, with in-depth interviews and ethnographic observation of group sessions, with the specific aim of describing the learning processes, coping, health and functional literacy, social and contextual issues.

Study Type

Interventional

Enrollment (Actual)

132

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint Denis De La Réunion, France, 97405
        • Department of endocrinology, University Hospital Reunion Island - Felix Guyon Site
    • La Réunion
      • Saint Benoît, La Réunion, France, 97470
        • Groupe Hopitalier Est Réunion
      • Saint Paul, La Réunion, France, 97863
        • Centre Hospitalier Gabriel Martin
      • Saint Pierre, La Réunion, France, 97448
        • Diabetolgy - UNiversity Hospital Sud Réunion

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Type 2 diabetes
  • HbA1c ≥ 7,5% more than 3 months
  • Adults
  • ≥ 1 year ADO and/or insulin and/or GLP-1 analog
  • antidiabetic treatment unchanged since 3 months (no change of treatment in the last 3 months, except for insulin dosage)
  • Living in Reunion Island
  • Affiliated to French national health insurance
  • Signed informed consent

Exclusion Criteria:

  • Treatment or associated conditions that would influence glycemic control, such as corticotherapy, cancer, inflammatory chronic diseases
  • Hospitalisation linked to diabetes < 3 months
  • Structured patient education in the past 3 months
  • Severe diabetes complications (e.g. ischemic or proliferative retinopathy, severe renal failure (clearance < 15 ml/min), acute ischemic heart disease (< 6 months, foot lesion)
  • Pregnancy (on-going or planned during the study)
  • Evolutive cancer
  • Physical or cognitive heavy handicap
  • Concomitant participation to a therapeutic trial

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 2 years self management education
Long-term program including initial self-management education program (1 to 7 sessions, based on individual assessment), and follow-up group sessions maintained for 2 years (4-monthly assessment, empowerment, and contextual action planning; facultative additional specific thematic sessions being delivered if needed).
After an initial intensive group education, four-monthly follow-up self-management group education sessions for 2 years. Each session is based on empowerment, socio-constructivism, social learning theory: personalized assessment (BG and risk factors, actions: realized, planned, achieved (or not), cognitive work, analysis of individual and social context and environment (facilitators, obstacles) then action planning. Specific additional sessions can be scheduled (food management, diabetes treatment and hypoglycemia, exercise, self monitoring of BG, insulin dosage, foot care). Sessions are framed, and structured, with patient booklet support. Sessions are delivered at the community level, by trained registered nurses, under the coordination of the health management network Reucare.
Active Comparator: Initial self-management education
Initial self-management group education: 1 to 7 sessions (< 3 months), based on individual assessment.
After an initial intensive group education, four-monthly follow-up self-management group education sessions for 2 years. Each session is based on empowerment, socio-constructivism, social learning theory: personalized assessment (BG and risk factors, actions: realized, planned, achieved (or not), cognitive work, analysis of individual and social context and environment (facilitators, obstacles) then action planning. Specific additional sessions can be scheduled (food management, diabetes treatment and hypoglycemia, exercise, self monitoring of BG, insulin dosage, foot care). Sessions are framed, and structured, with patient booklet support. Sessions are delivered at the community level, by trained registered nurses, under the coordination of the health management network Reucare.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mean change in glycated haemoglobin (GlyHb)
Time Frame: 0 and 2 years
0 and 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean change in glycated haemoglobin (GlyHb)
Time Frame: 0 and 1 year
0 and 1 year
change in GlyHb
Time Frame: quarterly up to 2 yrs
quarterly up to 2 yrs
Blood sugar and lipids
Time Frame: 1 and 2 yrs
Blood sugar Total, HDL and LDL cholesterol, triglycerides
1 and 2 yrs
diabetes complications
Time Frame: 1 and 2 yrs
retinopathy stages, micro-albuminuria or proteinuria, creatinine clearance, foot risk grade, ischemic heart or cerebral disease
1 and 2 yrs
health behaviours
Time Frame: 1 and 2 yrs
physical activity and diet (Baecke and food frequency questionnaires)
1 and 2 yrs
anti-diabetic therapy
Time Frame: 1 and 2 yrs
type, dosage
1 and 2 yrs
health care process
Time Frame: 1 and 2 yrs
medical follow-up and appointments, compliance (questionnaire)
1 and 2 yrs
Psychometric scales
Time Frame: 1 and 2 yrs
self-efficacy, social support, HAD (anxiety and depression)
1 and 2 yrs
Quality of Life
Time Frame: 1 and 2 yrs
short DQOL adapted and validated for Reunion
1 and 2 yrs
Change in tobacco consumption
Time Frame: quarterly up to 2 yrs
quarterly up to 2 yrs
Change in fasting blood glucose
Time Frame: quarterly up to 2 yrs
quarterly up to 2 yrs
Change in body mass index
Time Frame: quarterly up to 2 yrs
quarterly up to 2 yrs
Change in waist circumference
Time Frame: quarterly up to 2 yrs
quarterly up to 2 yrs
Change in blood pressure
Time Frame: quarterly up to 2 yrs
quarterly up to 2 yrs

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xavier Debussche, MD, Diabetology - University Hospital Reunion Island - Felix Guyon Site
  • Principal Investigator: Jean Luc YVIN, MD, Department of Internal Medicine - University Hospital Reunion Island - Felix Guyon Site
  • Principal Investigator: Stéphane SCHNEEBELI, MD, Diabetology - University Hospital Reunion Island - GHSR
  • Principal Investigator: Jean Hugues GATINA, MD, Centre Hospitalier Gabriel Martin
  • Principal Investigator: Yogananda THIRAPATHIAPPADU, MD, Groupe Hospitalier Est Réunion

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2011

Primary Completion (Actual)

September 1, 2016

Study Completion (Actual)

September 1, 2016

Study Registration Dates

First Submitted

August 26, 2011

First Submitted That Met QC Criteria

August 29, 2011

First Posted (Estimated)

August 30, 2011

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 4, 2024

Last Verified

January 1, 2024

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on Structured self-management group education during 2 years

3
Subscribe